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LETTER TO THE EDITOR
Reply: Sperm retrieval rates by
micro-TESE versus conventional
TESE in men with non-obstructive
azoospermia—the assumption of
independence in effects sizes might
lead to misleading conclusions
Sir,
We thank Esteves and co-authors (2020) for their constructive crit-
icisms of our meta-analysis. They essentially disagree with our conclu-
sions saying that the available evidence did not confirm the superiority
of microdissection testicular sperm extraction (micro-TESE) vs. con-
ventional TESE (cTESE) in the achievement of positive sperm retrieval
rate (SRR) in patients with non-obstructive azoospermia (NOA). The
main problems that Esteves et al. (2020) emphasized are the high het-
erogeneity and the inclusion of all studies with and without direct com-
parison. In addition, other methodological problems were identified.
First, we want to clarify that observational studies include case-
series, case-control, cross-sectional and longitudinal studies where
the independent variable is not under the control of the researcher
(Higgins & Green, 2008; Guyatt et al., 2011). In particular, it is important























































type of observational study deals with the evaluation of possible effects
of a treatment, or of an approach, where the assignment of subjects
into a specific group versus a control one is outside the control of the
investigator (Higgins & Green, 2008, Guyatt et al., 2011). As already
reported in our meta-analysis (Corona et al., 2019), all available studies
comparing mTESE vs. cTESE belong to the latter category of the
observational trials (Schlegel et al., 1997; Amer et al., 2000; Okada
et al., 2002; Tsujimura et al., 2002; Ramasamy et al., 2005; Ghalayini
et al., 2011; Salehi et al., 2017) except one, which is a randomised-
controlled trial (RCT, Colpi et al., 2009). All types of observational
trials, including comparison trials used by Bernie et al. (2015) in their
meta-analysis, by Deruyver et al. (2014) in their systematic review and
even in our meta-analysis, present important limitations. The limita-
tions include failure to develop and apply appropriate eligibility criteria,
flawed measurement of both exposure and outcome, failure to ade-
quately control confounding factors and incomplete follow-up (Guyatt
et al., 2011). For example, due to the lack of blinding assignment, physi-
cians might be more likely to use mTESE in healthier individuals with
more favourable clinical characteristics, leading to a higher probability
of reaching positive SRR. Accordingly, to better clarify the topic and try
to reduce the latter important source of bias, we decided to include in
our meta-analysis all observational studies using cTESE or mTESE for
SRR as correctly specified in the method section of our study Corona
et al., 2019 and in PROSPERO registration (https://www.crd.york.ac.
uk/PROSPERO/display_record.php?RecordID=92017).
Figure 1 Sperm retrieval rate (SRR) per testicular sperm extraction (TESE) cycle according to the type of surgical approach in
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Figure 2 Influence of the number of patients with Sertoli cell only syndrome (SCOS) in the whole sample. (A) and when
comparative studies were excluded (B). Data refer to studies reporting histological evaluation for the whole sample. The size of the circles indicates
sample dimension.
Regarding the methodological problems emphasized by Esteves et al.
(2020), we want to clarify that in order to reduce the risk of problems
related to data imputing, all data were blindly reviewed by four of the
authors (G.C., A.P., C.B. and N.S.) already involved in our work and by
one (W.V.) not previously involved in the analysis. Some differences,
when compared to the Esteves et al. (2020) analysis, were detected
(see Supplementary Table S1).
In addition, the following points need to be better elucidated.
Firstly, Esteves et al. (2020) pointed out the problem related to a
substantial evidence of bias observed in our meta-analysis since up to
43% of included mTESE studies involved selected patient populations
with an overall unfavourable prognosis, and by contrast, only 7.5%
of the cTESE studies included the so-called ‘unfavourable’ patients,































(2020) indication, we performed a sensitivity analysis by comparing
SRR in cTESE and mTESE in selected and unselected studies (see
Supplementary Table S1). Similar to what was observed in our overall
analysis, we did not observe any statistical differences between the two
techniques (SRR = 48[44;51]% vs. 49[45;53]%, Q = 0.44, P = 0.51 and
46[42;50]% vs.43[38;47]%, Q = 1.14; P = 0.28 for cTESE and mTESE in
unselected and selected studies, respectively; see also Fig. 1).
Secondly, Esteves et al. (2014), in their original study, found that
mTESE was able to detect higher SRR when compared to cTESE
when patients with Sertoli only syndrome (SCOS) or tubular atrophy
were considered. Hence, they reassessed the SRR in non-comparative
studies, included in our meta-analysis, showing that, when the analysis
was limited to patients with SCOS, mTESE resulted in a significantly
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possible to support one technique for a surgical approach taking into
account an outcome obtained only after a histological diagnosis, hence
at the end of the procedure. In addition, it is important to recognize
that SCOS is a specific histological diagnosis of testis specimens which
can result from different pathological conditions either congenital (pure
or primitive) or acquired (partial or secondary) (Anniballo et al., 2000;
Dohle et al., 2012). In the pure and complete form, the detection of
sperm is theoretically impossible whereas in secondary or partial SCOS
it may sometimes be possible. Hence, the correct testis histological
classification represents an essential and crucial point. However, several
classification systems have been described (Anniballo et al., 2000;
Dohle et al., 2012). Although Johnsen score represents the most widely
quoted and quantitative histological grading system, the use of different
classifications has resulted in a wide variation of diagnosis by different
pathologists, limiting the diagnostic and prognostic value of the testicu-
lar biopsy (Anniballo et al., 2000; Dohle et al., 2012). This is the reason
why we decided not to use the histological classification as a possible
confounder in our meta-analysis (Corona et al., 2019). In fact, it is our
opinion that it adds only a further source of bias. However, in order
to address Esteves et al.’s (2020) request, we carefully collected all the
studies reporting data on SCOS (Supplementary Table S1). In addition,
it is important to emphasize that several studies reported histological
classification only for a limited number of patients and not for the whole
population studied (see Supplementary Table S1). This represents a
further source of bias. By considering only studies which provided a
histological classification for all patients evaluated and by considering
only SOCS diagnosis as reported by the original authors (Supple-
mentary Table S1), we were unable to detect any prognostic value
of SCOS when a meta-regression analysis was performed (Fig. 2A).
Similar findings were observed when only non-comparative studies
were considered (Fig. 2B). The latter result confirms our hypothesis
regarding the limitations related to the use of different histological testis
classifications (Anniballo et al., 2000; Dohle et al., 2012). In line with
this finding, by applying the aforementioned criteria, when only non-
comparative studies were considered, we were not able to find any
difference when cTESE was compared to mTESE (SRR = 25[20;31] vs.
31[26;37], Q = 2.28; P = 0.13, for cTESE and mTESE, respectively; see
also Fig. 1).
Thirdly, Esteves et al. (2020) documented that when the analysis
was limited only to non-comparative studies providing confirmatory
diagnostic histopathology details, mTESE resulted in significantly higher
SRR when compared to cTESE. Similar to what was reported for
SCOS diagnosis, when the analysis was limited to only studies reporting
histological data in the whole sample and only non-comparative studies
were considered, we did not find any difference when cTESE was com-
pared to mTESE (SRR = 48[44;52] vs. 47[44;51], Q = 0.12; P = 0.73 for
cTESE and mTESE, respectively; see also Fig. 1).
As correctly indicated by Esteves et al. (2020) and already recognized
in our study limitations (Corona et al., 2019), high heterogeneity was
detected. An iterative analysis was performed by excluding outliers
in order to reduce the heterogeneity (<50%) of the study (Higgins
& Green, 2008). By performing a sensitivity analysis with a study het-
erogeneity <50% (I2 = 49.2), we confirmed the absence of difference
between cTESE and mTESE in SRR (SRR = 46[44;48] vs. 47[45;49],
Q = 0.83; P = 0.36 for cTESE and mTESE, respectively).
In conclusion, even after the new analysis of the data, according





























































































































evidence cannot support the superiority of mTESE vs. cTESE in SRR for
patients with NOA. We agree with Esteves et al. (2020) that further
high-quality RCTs are strongly advisable to better clarify this important
topic.
Supplementary data
Supplementary data are available at Human Reproduction Update online.
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